Royal Bank of Canada’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $156M | Buy |
434,255
+56,703
| +15% | +$17.3M | 0.02% | 534 |
|
|
2026
Q1 | $94.6M | Sell |
377,552
-67,308
| -15% | -$16.7M | 0.02% | 649 |
|
|
2025
Q4 | $122M | Sell |
444,860
-114,917
| -21% | -$31.4M | 0.02% | 573 |
|
|
2025
Q3 | $147M | Buy |
559,777
+16,020
| +3% | +$3.89M | 0.02% | 525 |
|
|
2025
Q2 | $119M | Buy |
543,757
+20,620
| +4% | +$4.41M | 0.02% | 558 |
|
|
2025
Q1 | $117M | Sell |
523,137
-2,351
| -0.4% | -$648K | 0.02% | 505 |
|
|
2024
Q4 | $172M | Buy |
525,488
+72,548
| +16% | +$22.8M | 0.03% | 396 |
|
|
2024
Q3 | $136M | Buy |
452,940
+44,804
| +11% | +$13.7M | 0.03% | 464 |
|
|
2024
Q2 | $134M | Buy |
408,136
+79,660
| +24% | +$28.2M | 0.03% | 437 |
|
|
2024
Q1 | $130M | Sell |
328,476
-13,221
| -4% | -$4.89M | 0.03% | 427 |
|
|
2023
Q4 | $120M | Buy |
341,697
+12,752
| +4% | +$4.51M | 0.03% | 460 |
|
|
2023
Q3 | $123M | Sell |
328,945
-11,183
| -3% | -$4.32M | 0.03% | 413 |
|
|
2023
Q2 | $130M | Buy |
340,128
+2,783
| +0.8% | +$994K | 0.03% | 416 |
|
|
2023
Q1 | $117M | Buy |
337,345
+65,458
| +24% | +$19.1M | 0.03% | 422 |
|
|
2022
Q4 | $64M | Sell |
271,887
-1,657
| -0.6% | -$393K | 0.02% | 598 |
|
|
2022
Q3 | $67.3M | Sell |
273,544
-890
| -0.3% | -$271K | 0.02% | 549 |
|
|
2022
Q2 | $83M | Buy |
274,434
+19,658
| +8% | +$6.4M | 0.02% | 489 |
|
|
2022
Q1 | $105M | Sell |
254,776
-53,375
| -17% | -$20.9M | 0.03% | 482 |
|
|
2021
Q4 | $145M | Sell |
308,151
-21,465
| -7% | -$9.24M | 0.03% | 414 |
|
|
2021
Q3 | $140M | Sell |
329,616
-71,893
| -18% | -$30.3M | 0.04% | 390 |
|
|
2021
Q2 | $144M | Buy |
401,509
+94,707
| +31% | +$31.3M | 0.04% | 384 |
|
|
2021
Q1 | $86.5M | Buy |
306,802
+5,656
| +2% | +$1.62M | 0.03% | 500 |
|
|
2020
Q4 | $85.3M | Sell |
301,146
-14,242
| -5% | -$4M | 0.02% | 503 |
|
|
2020
Q3 | $86.7M | Sell |
315,388
-14,859
| -4% | -$3.93M | 0.03% | 425 |
|
|
2020
Q2 | $75M | Buy |
330,247
+15,431
| +5% | +$3.03M | 0.03% | 446 |
|
|
2020
Q1 | $47.9M | Sell |
314,816
-15,784
| -5% | -$2.43M | 0.02% | 518 |
|
|
2019
Q4 | $49.7M | Sell |
330,600
-10,447
| -3% | -$1.52M | 0.02% | 631 |
|
|
2019
Q3 | $48.4M | Sell |
341,047
-26,577
| -7% | -$3.66M | 0.02% | 604 |
|
|
2019
Q2 | $46M | Sell |
367,624
-39,073
| -10% | -$4.61M | 0.02% | 620 |
|
|
2019
Q1 | $44.8M | Sell |
406,697
-57,661
| -12% | -$6M | 0.02% | 618 |
|
|
2018
Q4 | $45.5M | Sell |
464,358
-138,250
| -23% | -$15M | 0.02% | 557 |
|
|
2018
Q3 | $74.4M | Sell |
602,608
-33,430
| -5% | -$3.75M | 0.03% | 443 |
|
|
2018
Q2 | $63.2M | Sell |
636,038
-45,262
| -7% | -$4.17M | 0.03% | 470 |
|
|
2018
Q1 | $60.2M | Sell |
681,300
-31,551
| -4% | -$2.95M | 0.03% | 504 |
|
|
2017
Q4 | $70.3M | Sell |
712,851
-94,345
| -12% | -$9.25M | 0.03% | 449 |
|
|
2017
Q3 | $77.7M | Sell |
807,196
-21,589
| -3% | -$1.95M | 0.04% | 384 |
|
|
2017
Q2 | $78.3M | Sell |
828,785
-63,601
| -7% | -$5.85M | 0.04% | 371 |
|
|
2017
Q1 | $72.8M | Buy |
892,386
+53,447
| +6% | +$4.47M | 0.04% | 372 |
|
|
2016
Q4 | $71.2M | Sell |
838,939
-43,322
| -5% | -$3.41M | 0.04% | 386 |
|
|
2016
Q3 | $65.7M | Sell |
882,261
-572,942
| -39% | -$45.5M | 0.04% | 395 |
|
|
2016
Q2 | $110M | Sell |
1,455,203
-109,240
| -7% | -$7.95M | 0.07% | 238 |
|
|
2016
Q1 | $108M | Buy |
1,564,443
+8,075
| +0.5% | +$486K | 0.07% | 226 |
|
|
2015
Q4 | $93.7M | Sell |
1,556,368
-34,344
| -2% | -$2.07M | 0.06% | 252 |
|
|
2015
Q3 | $86.1M | Buy |
1,590,712
+7,090
| +0.4% | +$413K | 0.06% | 208 |
|
|
2015
Q2 | $92M | Sell |
1,583,622
-56,716
| -3% | -$3.17M | 0.06% | 218 |
|
|
2015
Q1 | $98.8M | Sell |
1,640,338
-107,811
| -6% | -$5.75M | 0.07% | 202 |
|
|
2014
Q4 | $93.1M | Buy |
1,748,149
+161,750
| +10% | +$8.09M | 0.06% | 245 |
|
|
2014
Q3 | $71M | Buy |
1,586,399
+57,487
| +4% | +$2.44M | 0.05% | 279 |
|
|
2014
Q2 | $64.5M | Buy |
1,528,912
+91,445
| +6% | +$3.92M | 0.04% | 302 |
|
|
2014
Q1 | $63.3M | Buy |
1,437,467
+20,194
| +1% | +$951K | 0.05% | 292 |
|
|
2013
Q4 | $69.5M | Buy |
1,417,273
+114,757
| +9% | +$5.37M | 0.05% | 288 |
|
|
2013
Q3 | $53.6M | Buy |
1,302,516
+176,120
| +16% | +$6.72M | 0.04% | 330 |
|
|
2013
Q2 | $39.6M | Buy |
+1,126,396
| New | +$37.1M | 0.03% | 404 |
|
Other funds holding WST
GIM
Royal Bank of Canada's WST Position: Q2 2026 in Review
Royal Bank of Canada increased its West Pharmaceutical (WST) stake by 15% in Q2 2026, buying an estimated $17.3M and bringing the position to 434,255 shares worth $156M. The position accounts for 0.02% of the portfolio, ranked #534.
Royal Bank of Canada first reported a position in WST in Q2 2013 and has held it in 53 quarters since. The position peaked at $172M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Royal Bank of Canada held 434,255 shares of West Pharmaceutical worth $156M as of Q2 2026.
- Royal Bank of Canada bought 56,703 West Pharmaceutical shares in Q2 2026, an estimated $17.3M.
- West Pharmaceutical made up 0.02% of Royal Bank of Canada's portfolio in Q2 2026, its #534 holding.
- Royal Bank of Canada first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's West Pharmaceutical position peaked at $172M in Q4 2024.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.